Rekha P Manghnani, MD
Pediatrics · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 3
- 2 carriers
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Manghnani’s office at (408) 297-9949 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A87029 · Current
Licensed to practise in California · since 2004 · expires 2028-05-31 · Nagpur University Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$8,208 in 2024
Medicaid paid $8,208 for 406 billed services this clinician did in 2024, up to 69 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Developmental screening | 46 | $4,161 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 31 | $1,330 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 28 | $967 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 23 | $783 |
| Screening test, pure tone, air only | 69 | $577 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 24 | $208 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 48 | $154 |
| Screening performed and negative | 23 | $29 |
| Medication list documented in medical record (COA) | 31 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 31 | $0 |
| Bilateral quantitative screening test of visual acuity | 21 | $0 |
| Return visit (30+ min) | 31 | $0 |
| 2024 | 406 | 12 | 69 | $8,208 |
| 2023 | 1,995 | 17 | 48 | $32,119 |
| 2022 | 1,631 | 11 | 49 | $31,777 |
| 2021 | 1,812 | 12 | 53 | $41,161 |
| 2020 | 1,525 | 13 | 73 | $34,041 |
| 2019 | 984 | 9 | 43 | $35,263 |
| 2018 | 1,054 | 10 | 61 | $26,509 |
See the largest Medicaid services in earlier years
2023
| Developmental screening | 207 | $17,476 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 85 | $3,990 |
| Screening test, pure tone, air only | 359 | $3,460 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 87 | $3,432 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 38 | $1,443 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 223 | $880 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use | 67 | $665 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 32 | $268 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 12 | $109 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 14 | $109 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 12 | $109 |
| Short return visit (20+ min) | 345 | $79 |
2022
| Developmental screening | 170 | $17,107 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 110 | $4,061 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 90 | $4,050 |
| Screening test, pure tone, air only | 365 | $3,450 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 51 | $1,690 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 104 | $784 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 133 | $525 |
| Screening performed and negative | 103 | $58 |
| Short return visit (20+ min) | 475 | $53 |
| Bilateral quantitative screening test of visual acuity | 18 | $0 |
| Return visit (30+ min) | 12 | $0 |
2021
| Developmental screening | 242 | $23,008 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 122 | $5,199 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 152 | $5,124 |
| Screening test, pure tone, air only | 385 | $3,366 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 67 | $2,439 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 142 | $1,132 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 146 | $572 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 51 | $127 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 12 | $119 |
| Short return visit (20+ min) | 422 | $75 |
| Bilateral quantitative screening test of visual acuity | 58 | $0 |
| Return visit (30+ min) | 13 | $0 |
2020
| Developmental screening | 182 | $18,860 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 110 | $3,867 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 87 | $3,627 |
| Screening test, pure tone, air only | 338 | $3,000 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 56 | $2,020 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 134 | $1,071 |
| Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use | 34 | $829 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 117 | $398 |
| Short return visit (20+ min) | 396 | $190 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 12 | $119 |
| Human Papillomavirus vaccine, types 6, 11, 16, 18, quadrivalent (4vHPV), 3 dose schedule, for intramuscular use | 12 | $60 |
| Bilateral quantitative screening test of visual acuity | 33 | $0 |
2019
| Developmental screening | 187 | $21,415 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 108 | $5,076 |
| Screening test, pure tone, air only | 291 | $3,495 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 64 | $2,473 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 22 | $1,330 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 86 | $794 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 33 | $327 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 35 | $186 |
| Short return visit (20+ min) | 158 | $169 |
2018
| Developmental screening | 155 | $12,369 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 150 | $6,526 |
| Screening test, pure tone, air only | 349 | $3,546 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 52 | $2,143 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 101 | $1,018 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 12 | $725 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 25 | $133 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, with microscopy | 17 | $48 |
| Bilateral quantitative screening test of visual acuity | 56 | $0 |
| Short return visit (20+ min) | 137 | $0 |
Money from drug and device companies
$154 in 2025
| 2025 | 2 | 4 | None | $154 |
| 2024 | 7 | 12 | None | $455 |
| 2023 | 4 | 10 | None | $144 |
| 2022 | 3 | 5 | None | $80 |
| 2021 | 3 | 3 | None | $53 |
| 2020 | 1 | 1 | None | $14 |
| 2019 | 2 | 3 | None | $65 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ARS Pharmaceuticals Operations | Neffy | $136 | 3 payments
|
| Merck Sharp & Dohme | Vaxelis | $19 | 1 payment
|
See all 4 published payments
| Merck Sharp & Dohme | Meals · 2025-09-03 | Vaxelis | $19 |
| ARS Pharmaceuticals Operations | Meals · 2025-04-30 | Neffy | $125 |
| ARS Pharmaceuticals Operations | Meals · 2025-02-05 | Neffy | $5 |
| ARS Pharmaceuticals Operations | Meals · 2025-01-06 | Neffy | $5 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $455
| Sanofi-Aventis U.S. | Tzield | $162 | 2 payments
|
| Novo Nordisk | None | $119 | 1 payment
|
| Pfizer | Prevnar 20 | $53 | 3 payments
|
| Sanofi Pasteur | Beyfortus | $44 | 2 payments
|
| Seqirus USA | Flucelvax | $32 | 2 payments
|
| Merck Sharp & Dohme | Gardasil | $30 | 1 payment
|
| Cranial Technologies | Doc Band | $16 | 1 payment
|
2023: $144
| Cranial Technologies | Doc Band | $64 | 5 payments
|
| Seqirus USA | Flucelvax Quadrivalent | $32 | 2 payments
|
| Pfizer | Prevnar 20 | $28 | 2 payments
|
| Sanofi Pasteur | Vaxelis | $20 | 1 payment
|
2022: $80
| Cranial Technologies | Doc Band | $50 | 3 payments
|
| Seqirus USA | Flucelvax Quadrivalent | $16 | 1 payment
|
| Pfizer | Prevnar 13 | $14 | 1 payment
|
2021: $53
| GlaxoSmithKline | Bexsero | $23 | 1 payment
|
| Cranial Technologies | Doc Band | $15 | 1 payment
|
| Seqirus USA | Flucelvax Quadrivalent | $14 | 1 payment
|
2020: $14
| Cranial Technologies | Doc Band | $14 | 1 payment
|
2019: $65
| Sanofi Pasteur | Adacel | $41 | 2 payments
|
| Alexion Pharmaceuticals | Strensiq | $24 | 1 payment
|
Professional record
- NPI
- 1609844026
- Licence
- CA A87029California A87029: Current · expires 2028-05-31
More record details
- Sole proprietor
- Yes
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- Po Box 906, Salida, CA, 95368
- NPI first listed
- 2006-03-10
- NPI last updated
- 2009-02-12
This is when the NPI record was last certified, not a medical board exam.